BRANFORD, Conn., Dec. 15, 2010 /PRNewswire/ -- HistoRx announces that Jack Davis has accepted its invitation to join the Board of Directors. As the former President and CEO of both a diagnostic product company and a laboratory testing company, he is an acknowledged diagnostic industry expert.
Mr. Davis was Co-founder, President, CEO and eventually Chairman of the Board at Dianon Systems, a leading provider of specialized clinical laboratory and anatomic pathology testing services and disease management systems focusing on cancer, pre-natal genetics and cytogenetics. Dianon Systems was sold to LabCorp in 2002. In addition, he served as President and CEO of Calypte Biomedical, a biodiagnostics company that developed the first urine-based HIV test, where he shepherded the company through its IPO. Previously, he was Division Vice President and worldwide General Manager of Abbott Laboratories Diagnostics Products business unit.
HistoRx CEO Rana K. Gupta approached Mr. Davis with the opportunity, commenting, "Now that HistoRx has proven our license model for diagnostics commercialization, it's crucial to expand our expertise in both the laboratory services business and the diagnostic product arena since these are the avenues of distribution we will continue to pursue. Jack's experience with running Abbott's worldwide Diagnostics Products business and with building a national anatomic pathology services business at Dianon make him a valuable addition to the HistoRx Board."
"I'm delighted to join the board of directors of HistoRx, a company that, working with the Pathology community at large, is committed to improving the objectivity, reproducibility and quantitation of anatomic pathology," Davis stated. "Testing services based on AQUA technology are improving the quality of care in cancer diagnostics."
About HistoRx (www.historx.com)
|SOURCE HistoRx, Inc.|
Copyright©2010 PR Newswire.
All rights reserved